Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Vorinostat, a histone deacetylase (HDAC) inhibitor, promotes cell cycle arrest and re-sensitizes rituximab- and chemo-resistant lymphoma cells to chemotherapy agents
Authors
Keywords
Vorinostat, Chemotherapy resistance, Lymphoma, Histone deacetylase inhibitors
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 142, Issue 2, Pages 379-387
Publisher
Springer Nature
Online
2015-08-27
DOI
10.1007/s00432-015-2026-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Lenalidomide monotherapy in relapsed primary cutaneous diffuse large B cell lymphoma-leg type
- (2013) P. Savini et al. ANNALS OF HEMATOLOGY
- The novel proteasome inhibitor carfilzomib induces cell cycle arrest, apoptosis and potentiates the anti-tumour activity of chemotherapy in rituximab-resistant lymphoma
- (2013) Juan J. Gu et al. BRITISH JOURNAL OF HAEMATOLOGY
- Clinical pharmacology profile of vorinostat, a histone deacetylase inhibitor
- (2013) Marian Iwamoto et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Non-Hodgkin’s B-cell lymphoma: Advances in molecular strategies targeting drug resistance
- (2013) Steve A Maxwell et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Reciprocal expression of the endocytic protein HIP1R and its repressor FOXP1 predicts outcome in R-CHOP-treated diffuse large B-cell lymphoma patients
- (2013) K K Wong et al. LEUKEMIA
- Inhibition of pan-class I phosphatidyl-inositol-3-kinase by NVP-BKM120 effectively blocks proliferation and induces cell death in diffuse large B-cell lymphoma
- (2013) Chuanbing Zang et al. LEUKEMIA & LYMPHOMA
- The role of p21waf1/cip1 and p27Kip1 in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma
- (2013) A Newbold et al. ONCOGENE
- The Sensitivity of Diffuse Large B-Cell Lymphoma Cell Lines to Histone Deacetylase Inhibitor-Induced Apoptosis Is Modulated by BCL-2 Family Protein Activity
- (2013) Ryan C. Thompson et al. PLoS One
- The Anti-Tumor Effects and Molecular Mechanisms of Suberoylanilide Hydroxamic Acid (SAHA) on the Aggressive Phenotypes of Ovarian Carcinoma Cells
- (2013) Shuo Chen et al. PLoS One
- Pharmacokinetics of fostamatinib, a spleen tyrosine kinase (SYK) inhibitor, in healthy human subjects following single and multiple oral dosing in three phase I studies
- (2012) Muhammad Baluom et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Apoptosis Induction by SAHA in Cutaneous T-Cell Lymphoma Cells Is Related to Downregulation of c-FLIP and Enhanced TRAIL Signaling
- (2012) Nadya Al-Yacoub et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Histone deacetylase inhibition restores cisplatin sensitivity of Hodgkin's lymphoma cells
- (2012) Stefanie Kewitz et al. LEUKEMIA RESEARCH
- Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era
- (2010) Christian Gisselbrecht et al. JOURNAL OF CLINICAL ONCOLOGY
- Acquired Resistance to Rituximab Is Associated with Chemotherapy Resistance Resulting from Decreased Bax and Bak Expression
- (2008) S. H. Olejniczak et al. CLINICAL CANCER RESEARCH
- Acquirement of Rituximab Resistance in Lymphoma Cell Lines Is Associated with Both Global CD20 Gene and Protein Down-Regulation Regulated at the Pretranscriptional and Posttranscriptional Levels
- (2008) M. S. Czuczman et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search